Gary J Bridger

Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

Dominique Schols, M. Lederman, C. Flexner, 2004, Journal of acquired immune deficiency syndromes.

Molecular Mechanism of Action of Monocyclam Versus Bicyclam Non-peptide Antagonists in the CXCR4 Chemokine Receptor*

Dominique Schols, T. Schwartz, M. Rosenkilde, 2007, Journal of Biological Chemistry.

AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity.

Dominique Schols, D. Schols, G. Bridger, 2002, The American journal of pathology.

Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.

Dominique Schols, E. De Clercq, D. Schols, 2010, Journal of medicinal chemistry.

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.

Dominique Schols, E. De Clercq, T. Schwartz, 2005, Biochemical pharmacology.